Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning.
Alvin Yuan Ming LeeKenneth ChenYu Guang TanHan Jie LeeVipatsorn ShutchaidatStephanie Fook-ChongChristopher W S ChengHenry S S HoJohn S P YuenNye Thane NgoYan Mee LawKae Jack TayPublished in: Prostate cancer and prostatic diseases (2022)
Reducing the number of systematic biopsies when performing an MRI-targeted biopsy leads to reduced detection of csPCa and alter the treatment plans for focal therapy, possibly limiting its oncological efficacy.